Purpose: To determine the possibility of plasma citrate as a biomarker in patients with glaucoma.
Methods: Twenty-one consecutive Caucasian patients with glaucoma and 21 sex- and age-matched controls were investigated. Plasma citrate, plasma creatinine, urine citrate, and urine creatinine were analyzed by ion chromatography.